Form D · Other
Aura Health Inc.
Toronto, A6 · CIK 0001766434
Offering snapshot reported Feb 7, 2019 · SEC filing
- Reported sold
- $38.3K Offering amount: $38.3K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 10, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 7, 2019 | Initial | $38,273 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-332384
Offering was effectuated in Canadian dollars. The amount in Canadian dollars was converted to U.S. dollars using a ratio of CAD$1.00=US$0.76.
Source: Form D, filed Feb 7, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Chris Carl | Director |
| Daniel Cohen | Executive |
| Vernon Frazier | Director |
| Joel Freudman | Director |
| Keith Li | Executive |
| Paul Mc Clory | Director |
| David Posner | Director |
| Robert Schwartz | Director |
Issuer details
Industry: Other (See others in industry)
Address:
2905 77 King Street West
Toronto, A6, M5K 1H2
Toronto, A6, M5K 1H2